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Laboratory
Exposure to
Influenza A H2N2,
Germany,
2004–2005 
To the Editor: From November
2004 to February 2005, a company
contracted by the College of
American Pathologists (CAP) sent
influenza quality assurance samples
containing live influenza A H2N2
viruses (A/Japan/305/57) to 3,748
international laboratories (1,2). Of
these, 3,686 (98%) were located in
Canada or the United States. In
Germany, 6 laboratories received at
least 1 of 3 samples, 2 for virus anti-
gen detection and 1 for virus culture;
all contained live virus and were for-
matted identically. No information on
infectivity or virulence of the samples
was available. Because of the absence
of human-to-human influenza A
H2N2 virus transmission since 1968,
this situation provided the rare oppor-
tunity to investigate whether infec-
tions with this strain had occurred in
any of the laboratories.
We used a standardized question-
naire to obtain from the laboratories
information on when the CAP sam-
ples had been received, which of the 3
quality assurance specimens they con-
tained, and how many employees had
been involved in their handling. A
second questionnaire was distributed
to personnel in microbiology and
virology departments. This elicited
information regarding routine labora-
tory activities, contact with CAP sam-
ples, tasks performed in conjunction
with handling of the samples, and any
influenzalike symptoms (sudden
onset of fever, cough, headache, and
muscle pain) within the respective
time frame. Persons who had worked
in a receiving laboratory from
September 1, 2004, to April 15, 2005,
and had performed routine procedures
in virology (defined as transport of
samples, preparation of samples for
diagnostic testing, antigen testing,
nucleic acid amplification testing, and
virus isolation) were eligible for the
study. From May 4 to May 19, 2005,
we visited the laboratories to inter-
view supervisory personnel regarding
routine work-up of samples and to
collect blood from study participants
for serologic testing.
The national reference laboratory
for influenza at Robert Koch Institute
performed serologic testing for anti-
bodies against A/Singapore/1/57
(H2N2) virus by hemagglutination
inhibition. We compared antibody
titers of laboratory workers who
worked with a CAPsample with those
who did not. However, this compari-
son might not show a difference if
(silent) virus transmission had
occurred among laboratory staff. To
exclude this possibility, we also com-
pared titers of workers born before
1969 with those in a group of volun-
teers from Robert Koch Institute also
born before 1969. Titers <10 were
assigned a value of 1.
Of 47 laboratory workers, 18
either declined to participate or were
excluded because they did not per-
form any of the defined routine proce-
dures during the defined period. Thus,
29 (62%) workers were included in
the study, of whom 14 (48%) reported
having worked with CAP samples. Of
these 14 workers, 12 (2 exclusively)
transported samples and 11 (2 exclu-
sively) prepared the samples; 9 (1
exclusively) performed antigen test-
ing, 2 (0) performed nucleic acid
amplification tests and 4 (0) per-
formed virus isolation. Fourteen
workers (48%) reported no contact
with the samples, and 1 (3%) was
unsure. None of the 29 participants
reported any event that could have led
to release of infectious material dur-
ing the respective time frame, such as
broken test tubes or dropped culture
plates. Participating laboratories
reported that all procedures were per-
formed under appropriate hygienic
and safety precautions. No person had
≥3 symptoms typical for influenzalike
illness in the 4 days after having
worked with a CAP sample.
Specific influenza A H2N2 anti-
body titers were determined in 25
study participants. None had a titer
>80, two (8%) had a titer of 80, three
(12%) had titers of 40, two (8%) had
titers of 20, and the remaining 18
(72%) had titers <10. Three (21%) of
14 workers exposed to CAP samples
and 4 (40%) of 10 who denied expo-
sure had titers ≥20. All 7 were born
before 1969. The geometric mean of
titers of all participating workers born
before 1969 did not differ significant-
ly from that of the Robert Koch
Institute employees (p = 0.28; Figure).
In summary, no evidence was
found for laboratory infections with
the influenza A H2N2 virus. The risk
for laboratory-acquired influenza
infections is unknown. Severe acute
respiratory syndrome coronavirus and
Mycobacterium tuberculosis are
infectious agents whose transmission
characteristics are similar to those of
influenza. For severe acute respiratory
syndrome coronavirus, laboratory-
acquired infections are well docu-
mented (3,4). For M.  tuberculosis,
there are strong indications that they
occur (5–7). From a public health per-
spective and in view of the current
importance given to influenza and a
possible pandemic, accurate charac-
terization of the risk for influenza
infections in laboratory settings is
needed. The small number of persons
included in this study limits the
conclusions that can be drawn.
Potentially exposed workers were
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presumably tested in other laborato-
ries involved, but we are not aware of
any publications to this end. The lack
of evidence for laboratory-acquired
infection with A H2N2 in our study
suggests that the risk was low under
controlled laboratory conditions.
However, only a large-scale serologic
study (which might still feasibly be
undertaken) could further substantiate
this finding. 
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Methicillin-
resistant
Staphylococcus
aureus in Cat and
Owner 
To the Editor: A 3-year-old,
neutered male, domestic shorthaired
cat was referred for treatment to a vet-
erinary specialty clinic in San
Francisco, California, with a 1-year
history of multifocal patches of crust-
ed and well-demarcated ulcers on the
trunk. Initially, small crusts suspected
to be associated with flea allergy and
pyoderma were present; however,
response was poor to multiple treat-
ments, including repeated corticos-
teroid therapy and antimicrobial ther-
apy with amoxicillin–clavulanic acid
and enrofloxacin. The owner reported
having skin abscesses and pneumonia
3 months earlier, although no microbi-
ologic testing was performed.
Cytologic evaluation of exudate
from the cat’s lesions identified neu-
trophils and eosinophils with engulfed
cocci. Leukocytosis with eosinophilia
was found on a complete blood cell
count. No notable abnormalities were
present on thoracic radiograph,
abdominal ultrasonograph, urinalysis,
and tests for feline leukemia and
immunodeficiency virus. Skin biopsy
specimens were collected for histo-
logic examination, and swabs of the
exudates were submitted for bacterial
culture. Histopathologic findings
demonstrated ulcers and dermal gran-
ulation tissue with linearly arranged
eosinophils, mast cells, neutrophils,
and plasma cells between dense,
homogeneous collagen bundles (scle-
rosing dermatitis). This pattern of
inflammation is distinct from most
staphylococcal infections of the skin,
and it has been suggested that this
uncommon histologic finding in cats
is associated with methicillin-resistant
staphylococcal infection (1).
Methicillin-resistant  Staphylo-
coccus aureus (MRSA) was isolated
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Figure. Titers of antibodies to influenza A H2N2 virus in laboratory personnel (n = 25; 13
born before 1969) and a comparison group born before 1969 (n = 32). The age listed is
that in 2005. Titers <10 were assigned a value of 1.